Article
Retrospective evaluation of human genetic evidence for clinical trial success using Mendelian randomization and machine learning
2026-02-23
Abstract excerpt
Human genetics has become a cornerstone of drug target discovery, yet the value of Mendelian randomization (MR) for predicting clinical success remains uncertain. Here, we systematically evaluated MR across 11,482 target–indication pairs with documented Phase II clinical outcomes to assess its utility for drug development. We find that MR statistical significance alone does not enrich for Phase II success, in cont...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 70d7fcee-3f6e-5d25-bc33-b4c43a5f71d9
- DOI
- 10.64898/2026.02.19.26346536
